Key Record Dates
ClinicalTrials.gov Identifier: | NCT03822117 |
---|---|
Brief Title: | Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) |
First Submitted : | January 28, 2019 |
First Submitted that Met QC Criteria : | January 28, 2019 |
First Posted : | January 30, 2019 |
Last Update Submitted that Met QC Criteria : | October 28, 2020 |
Last Update Posted : | October 30, 2020 |